Photos from a fiery 3-hour Senate hearing with Robert F. Kennedy Jr.

WASHINGTON (AP) — U.S. Health Secretary Robert F. Kennedy Jr. faced pointed bipartisan questioning during a contentious three-hour Senate hearing Thursday addressing his efforts to pull back COVID-19 vaccine recommendations and the turmoil he has created at federal health agencies.

This is a photo gallery curated by AP photo editors.

Secretary of Health and Human Services Robert F. Kennedy Jr., appears before the Senate Finance Committee, on Capitol Hill in Washington, Thursday, Sept. 4, 2025. (AP Photo/Mark Schiefelbein)

Sen. Tina Smith, D-Minn., speaks as Secretary of Health and Human Services Robert F. Kennedy Jr., appears before the Senate Finance Committee, on Capitol Hill in Washington, Thursday, Sept. 4, 2025. (AP Photo/Mark Schiefelbein)

Sen. Mark Warner, D-Va., speaks as Secretary of Health and Human Services Robert F. Kennedy Jr., appears before the Senate Finance Committee, on Capitol Hill in Washington, Thursday, Sept. 4, 2025. (AP Photo/Mark Schiefelbein)

Secretary of Health and Human Services Robert F. Kennedy Jr., appears before the Senate Finance Committee, on Capitol Hill in Washington, Thursday, Sept. 4, 2025. (AP Photo/Mark Schiefelbein)

Sen. Elizabeth Warren, D-Mass., speaks as Secretary of Health and Human Services Robert F. Kennedy Jr., appears before the Senate Finance Committee, on Capitol Hill in Washington, Thursday, Sept. 4, 2025. (AP Photo/Mark Schiefelbein)

Secretary of Health and Human Services Robert F. Kennedy Jr., appears before the Senate Finance Committee, on Capitol Hill in Washington, Thursday, Sept. 4, 2025. (AP Photo/Mark Schiefelbein)

Sen. Bill Cassidy, R-La., left, talks with Sen. Steve Daines, R-Mont., as Secretary of Health and Human Services Robert F. Kennedy Jr., appears before the Senate Finance Committee, on Capitol Hill in Washington, Thursday, Sept. 4, 2025. (AP Photo/Mark Schiefelbein)

Secretary of Health and Human Services Robert F. Kennedy Jr., appears before the Senate Finance Committee, on Capitol Hill in Washington, Thursday, Sept. 4, 2025. (AP Photo/Mark Schiefelbein)

Sen. Ben Ray Lujan, D-N.M., speaks as Secretary of Health and Human Services Robert F. Kennedy Jr., appears before the Senate Finance Committee, on Capitol Hill in Washington, Thursday, Sept. 4, 2025. (AP Photo/Mark Schiefelbein)

Health and Human Services Secretary Robert F. Kennedy Jr., appears before the Senate Finance Committee on Capitol Hill in Washington, Thursday, Sept. 4, 2025. (AP Photo/J. Scott Applewhite)

Sen. Bernie Sanders, I-Vt., listens as Secretary of Health and Human Services Robert F. Kennedy Jr., appears before the Senate Finance Committee, on Capitol Hill in Washington, Thursday, Sept. 4, 2025. (AP Photo/Mark Schiefelbein)

Secretary of Health and Human Services Robert F. Kennedy Jr., appears before the Senate Finance Committee, on Capitol Hill in Washington, Thursday, Sept. 4, 2025. (AP Photo/Mark Schiefelbein)

Sen. Raphael Warnock, D-Ga., speaks as Secretary of Health and Human Services Robert F. Kennedy Jr., appears before the Senate Finance Committee, on Capitol Hill in Washington, Thursday, Sept. 4, 2025. (AP Photo/Mark Schiefelbein)

Secretary of Health and Human Services Robert F. Kennedy Jr., arrives before the Senate Finance Committee, on Capitol Hill in Washington, Thursday, Sept. 4, 2025. (AP Photo/Mark Schiefelbein)

Secretary of Health and Human Services Robert F. Kennedy Jr., appears before the Senate Finance Committee, on Capitol Hill in Washington, Thursday, Sept. 4, 2025. (AP Photo/Mark Schiefelbein)

NEWARK, Del.--(BUSINESS WIRE)--Jan 15, 2026--

QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle Argus, a premier pharmacovigilance system designed to support comprehensive safety case management for clinical trials.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260115711485/en/

The adoption of the Oracle Argus drug safety platform underscores QPS’s commitment to advancing patient safety, regulatory compliance, and operational excellence across its clients’ clinical drug development programs. Integrating this industry-standard safety platform strengthens QPS’ ability to capture, manage, and report adverse events in accordance with global regulatory requirements.

“Ensuring patient safety and data integrity is at the heart of what we do when conducting clinical trials,” said Derek Grimes, Executive Vice President of QPS. “Oracle Argus provides us with a robust, scalable solution to support the growing needs of our customer’s clinical trial portfolios and the evolving expectations of regulatory authorities worldwide.”

“Oracle Argus provides QPS Holdings, LLC with a trusted, globally recognized drug safety platform that supports compliance with stringent pharmacovigilance standards and regulations, while streamlining end-to-end safety operations and insights at scale,” said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. “With our industry-leading solutions, QPS Holdings, LLC can further transform and elevate its safety case management for customers worldwide.”

The deployment of Oracle Argus will enable QPS to:

As the demand for innovative therapies continues to rise, CROs play a critical role in managing both development speed and patient safety. By leveraging the Oracle Argus platform, QPS is well-positioned to deliver on its mission to accelerate pharmaceutical breakthroughs across the globe by delivering custom-built research services.

###

ABOUT QPS HOLDINGS, LLC

QPS is a global, full-service, GLP/GCP-compliant contract research organization (CRO) delivering the highest grade of discovery, bioanalysis, preclinical and clinical drug development services. Since 1995, QPS has grown from a small bioanalysis shop into a full-service CRO with 1,200+ employees in the US, Europe, Asia and India. Today, QPS offers expanded pharmaceutical contract R&D services with special expertise in pharmacology, DMPK, toxicology, bioanalysis, translational medicine, PBMC processing, central safety labs, clinical trials, and clinical research services. An award-winning leader focused on bioanalysis and clinical trials, QPS is known for proven quality standards, technical expertise, a flexible approach to research, client satisfaction, turnkey laboratories, Phase I/II clinical units, and multi-site clinical research services. For more information, visit http://www.qps.com or email info@qps.com.

ABOUT ORACLE ARGUS

Oracle Argus is an industry-leading, trusted solution for processing, analyzing, and reporting adverse event cases originating in pre-market and post-market drugs, biologics, vaccines, devices, and combination products. Oracle has been a Leader in the IDC MarketScape: Worldwide Life Science R&D Pharmacovigilance Technology Solutions and Consulting Services 2025 Vendor Assessment (doc # US53669225, July 2025). To learn more about Oracle’s pharmacovigilance portfolio visit: https://www.oracle.com/life-sciences/safety-solutions/argus-safety-case-management/. Trademarks: Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation.

Derek Grimes, EVP, Global Head of Clinical Research at QPS Holdings, LLC.